Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury.
Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury.
复制标题
DOI:
10.1007/s10875-010-9404-7
复制
发表时间:
2010-05
影响因子:
9.1
通讯作者:
Nguyen, Dung H.
中科院分区:
文献类型:
--
作者:
Fehlings, Michael G.;Nguyen, Dung H.
Spinal cord injury (SCI) is caused by two related but mechanistically distinct events: the primary injury to the spinal cord is caused by a mechanic trauma; the secondary injury is a cascade of cellular and molecular events that exacerbates the initial damage. Neuroinflammation, an important event in the secondary injury cascade, is critical in the clearance of cellular debris after SCI. However, leukocytes and microglia, recruited to the injury site during neuroinflammation, can exacerbate the initial damage following SCI by secreting reactive oxygen species, matrix-metalloproteinase, and proinflammatory cytokines. Therefore, attenuating the activity of leukocytes and microglia is an attractive therapeutic strategy to reduce the neurological deficit associated with SCI. In this regard, immunoglobulin G (IgG) is a potential treatment candidate. IgG has been used clinically to treat autoimmune disease and has been demonstrated to attenuate the activities of leukocytes and microglia. In this review, we discuss the potential use of IgG for SCI based on the current understanding of the immune-modulating mechanism of IgG and the role of neuroinflammation in SCI.
登录
查看更多内容
影响因子:
20.3
作者:
von Gunten, Stephan;Schaub, Alexander;Simon, Hans-Uwe
通讯作者:
Simon, Hans-Uwe
影响因子:
3.6
作者:
Clark, RSB;Kochanek, PM;Watkins, SC
通讯作者:
Watkins, SC
影响因子:
15.9
作者:
Hauben, E;Agranov, E;Schwartz, M
通讯作者:
Schwartz, M
DOI:
10.1073/pnas.0810163105
发表时间:
2008-12-16
影响因子:
11.1
作者:
Anthony, Robert M.;Wermeling, Fredrik;Ravetch, Jeffrey V.
通讯作者:
Ravetch, Jeffrey V.
影响因子:
14.5
作者:
Fleming, Jennifer C.;Norenberg, Michael D.;Weaver, Lynne C.
通讯作者:
Weaver, Lynne C.